Sustainability

Patients

Improving lives and efficient resource use with sustainable healthcare

With patients in focus, Camurus strives to reduce the impact of severe and chronic diseases, such as opioid dependence and rare diseases.

The goal is to be able to offer medicines with improved treatment outcomes, that provide an increased quality of life and a more efficient use of resources – thereby also contributing to a sustainable healthcare.

Material aspects

Access to medicine

We aim to increase access to our products for as many people as possible. Camurus supports and collaborates with healthcare and patient organizations to reduce stigma and improve disease awareness – an important part of the work.

Patient health and safety (incl. responsbible product labeling)

Patient safety is of highest priority, and Camurus follows and monitors marketed products for any product complaint and possible side effects. These are reported to health authorities in accordance with applicable laws and regulations.

Innovation

Camurus utilizes its long-acting Fluidcrystal® technology and extensive R&D expertise to develop innovative pharmaceutical medicines aimed at improving the lives of patients with severe and chronic diseases. Learn more at science

Ethics in R&D (incl. clinical studies and animal welfare)

Development of new medicines, both pre-clinical, e.g. animal testing, and clinical studies are conducted in accordance with applicable legislations, governing documents and quality system to steer for instance accurate and objective reporting, transparency, high ethics and patient integrity.

Our goals by 2026

Reach 100,000 patients in treatment with Buvidal®¹⁾
Conduct annual projects focused on reducing stigma for patients
Take at least one new drug to regulatory approval

Our achievements

48,000
patients
estimated in treatment with Buvidal® at the end of 2023^*
20+
countries
where Buvidal is available^*
3
projects
conducted in 2023 focused on reducing stigma^*

^{*as at end December 2023, source: Annual Report 2023}

Access to medicines

Camurus aims to improve access to effective and convenient treatments for patients with severe and chronic diseases, such as opioid dependence and rare diseases. The goal is to increase access to treatments to potentially improve quality of life for as many people as possible.

Learn more about our work and approach

Ethics in clinical trials

Camurus is determined to conduct clinical trials in an ethical manner. This includes protecting the safety, well-being and legal rights of all participants, and adhere to the highest ethical standards for clinical research.